BACKGROUND: Filaggrin (FLG) mutations are major genetic determinants for eczema, but their role in eczema severity needs further investigation. Children with eczema are at higher risk of having asthma and rhinitis but it is not known if this risk is associated with the severity of eczema. OBJECTIVES: To investigate eczema severity in relation to sex, FLG mutations, asthma, rhinitis and topical treatment among preadolescent children in a population-based cohort. METHODS: Parental questionnaires were used to obtain data on symptoms of eczema, asthma, and rhinitis among 3301 preadolescent children. Eczema severity was evaluated based on sleep disturbance, extent of disease and total time with eczema the previous year. Genotyping was performed in 1854 individuals for three common FLG mutations (R501X, R2447X and 2282del4). Results Eczema was more prevalent among girls (14·5%) than boys (9·4%). FLG mutations were detected in 13·1% of children with mild eczema and 12·5% with moderate-to-severe eczema. Of children with moderate-to-severe eczema, 45·1% had rhinitis and 22·0% had asthma compared with 32·7% and 13·8% of children with mild eczema, respectively. Children with moderate-to-severe eczema used moisturizers and topical glucocorticoids more frequently than children with mild eczema. Boys used moisturizers less frequently than girls. CONCLUSIONS: More preadolescent girls than boys had eczema. FLG mutations did not influence eczema severity in our population-based cohort. Prevalence of rhinitis and asthma was associated with eczema severity, with the highest prevalence among boys with moderate-to-severe eczema.
BACKGROUND:Filaggrin (FLG) mutations are major genetic determinants for eczema, but their role in eczema severity needs further investigation. Children with eczema are at higher risk of having asthma and rhinitis but it is not known if this risk is associated with the severity of eczema. OBJECTIVES: To investigate eczema severity in relation to sex, FLG mutations, asthma, rhinitis and topical treatment among preadolescent children in a population-based cohort. METHODS: Parental questionnaires were used to obtain data on symptoms of eczema, asthma, and rhinitis among 3301 preadolescent children. Eczema severity was evaluated based on sleep disturbance, extent of disease and total time with eczema the previous year. Genotyping was performed in 1854 individuals for three common FLG mutations (R501X, R2447X and 2282del4). Results Eczema was more prevalent among girls (14·5%) than boys (9·4%). FLG mutations were detected in 13·1% of children with mild eczema and 12·5% with moderate-to-severe eczema. Of children with moderate-to-severe eczema, 45·1% had rhinitis and 22·0% had asthma compared with 32·7% and 13·8% of children with mild eczema, respectively. Children with moderate-to-severe eczema used moisturizers and topical glucocorticoids more frequently than children with mild eczema. Boys used moisturizers less frequently than girls. CONCLUSIONS: More preadolescent girls than boys had eczema. FLG mutations did not influence eczema severity in our population-based cohort. Prevalence of rhinitis and asthma was associated with eczema severity, with the highest prevalence among boys with moderate-to-severe eczema.
Authors: Katrina Abuabara; Ole Hoffstad; Andrea B Troxel; Joel M Gelfand; Charles E McCulloch; David J Margolis Journal: J Allergy Clin Immunol Date: 2017-06-17 Impact factor: 10.793
Authors: Anneliese Willems; Amanda Tapley; Alison Fielding; Er Tsing Vivian Tng; Elizabeth G Holliday; Mieke L van Driel; Jean I Ball; Andrew R Davey; Irena Patsan; Kristen FitzGerald; Neil A Spike; Parker J Magin Journal: Dermatol Pract Concept Date: 2021-09-01
Authors: Kevin Mortimer; Maia Lesosky; Luis García-Marcos; M Innes Asher; Neil Pearce; Eamon Ellwood; Karen Bissell; Asma El Sony; Philippa Ellwood; Guy B Marks; Antonela Martínez-Torres; Eva Morales; Virginia Perez-Fernandez; Steven Robertson; Charlotte E Rutter; Richard J Silverwood; David P Strachan; Chen-Yuan Chiang Journal: Eur Respir J Date: 2022-09-15 Impact factor: 33.795
Authors: Jocelyn M Biagini; John W Kroner; Asel Baatyrbek Kyzy; Alexandra Gonzales; Hua He; Mariana Stevens; Brittany Grashel; Daniel Spagna; Samuel Paul; Rahul Patel; Angelo Bucci; Michael G Sherenian; Liza Bronner Murrison; Lisa J Martin; Gurjit K Khurana Hershey Journal: J Allergy Clin Immunol Date: 2021-10-18 Impact factor: 14.290
Authors: Ingo Marenholz; Jorge Esparza-Gordillo; Franz Rüschendorf; Anja Bauerfeind; David P Strachan; Ben D Spycher; Hansjörg Baurecht; Patricia Margaritte-Jeannin; Annika Sääf; Marjan Kerkhof; Markus Ege; Svetlana Baltic; Melanie C Matheson; Jin Li; Sven Michel; Wei Q Ang; Wendy McArdle; Andreas Arnold; Georg Homuth; Florence Demenais; Emmanuelle Bouzigon; Cilla Söderhäll; Göran Pershagen; Johan C de Jongste; Dirkje S Postma; Charlotte Braun-Fahrländer; Elisabeth Horak; Ludmila M Ogorodova; Valery P Puzyrev; Elena Yu Bragina; Thomas J Hudson; Charles Morin; David L Duffy; Guy B Marks; Colin F Robertson; Grant W Montgomery; Bill Musk; Philip J Thompson; Nicholas G Martin; Alan James; Patrick Sleiman; Elina Toskala; Elke Rodriguez; Regina Fölster-Holst; Andre Franke; Wolfgang Lieb; Christian Gieger; Andrea Heinzmann; Ernst Rietschel; Thomas Keil; Sven Cichon; Markus M Nöthen; Craig E Pennell; Peter D Sly; Carsten O Schmidt; Anja Matanovic; Valentin Schneider; Matthias Heinig; Norbert Hübner; Patrick G Holt; Susanne Lau; Michael Kabesch; Stefan Weidinger; Hakon Hakonarson; Manuel A R Ferreira; Catherine Laprise; Maxim B Freidin; Jon Genuneit; Gerard H Koppelman; Erik Melén; Marie-Hélène Dizier; A John Henderson; Young Ae Lee Journal: Nat Commun Date: 2015-11-06 Impact factor: 14.919